These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3731102)

  • 1. Reversal of multidrug resistance by synthetic isoprenoids in the KB human cancer cell line.
    Nakagawa M; Akiyama S; Yamaguchi T; Shiraishi N; Ogata J; Kuwano M
    Cancer Res; 1986 Sep; 46(9):4453-7. PubMed ID: 3731102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overcoming drug resistance in cancer cells with synthetic isoprenoids.
    Yamaguchi T; Nakagawa M; Shiraishi N; Yoshida T; Kiyosue T; Arita M; Akiyama S; Kuwano M
    J Natl Cancer Inst; 1986 May; 76(5):947-53. PubMed ID: 3457980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Techniques to reverse or circumvent drug-resistance in vitro.
    Kuwano M; Nakagawa M; Shiraishi N; Yamaguchi T; Kikuchi J; Akiyama S
    Prog Clin Biol Res; 1986; 223():163-71. PubMed ID: 3809198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of bisbenzylisoquinoline (biscoclaurine) alkaloids on multidrug resistance in KB human cancer cells.
    Shiraishi N; Akiyama S; Nakagawa M; Kobayashi M; Kuwano M
    Cancer Res; 1987 May; 47(9):2413-6. PubMed ID: 3567927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taxol resistance and its reversal by synthetic isoprenoids in human bladder cancer cell line.
    Nakagawa M; Enokida H; Gotanda T; Tachiwada T; Imazono Y; Kubo H; Nishiyama K; Suzuki S; Inomata K; Kishiye T
    Aktuelle Urol; 2003 Jul; 34(4):250-2. PubMed ID: 14566676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic isoprenoid photoaffinity labeling of P-glycoprotein specific to multidrug-resistant cells.
    Akiyama S; Yoshimura A; Kikuchi H; Sumizawa T; Kuwano M; Tahara Y
    Mol Pharmacol; 1989 Nov; 36(5):730-5. PubMed ID: 2573823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and -sensitive KB cells: effects of verapamil and other drugs.
    Willingham MC; Cornwell MM; Cardarelli CO; Gottesman MM; Pastan I
    Cancer Res; 1986 Nov; 46(11):5941-6. PubMed ID: 3756931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of vincristine and actinomycin D by a new synthetic imidazole anti-tumor agent YM534 active against human cancer cells and multidrug-resistant cells.
    Sato S; Watanabe Y; Okamura K; Hamanaka R; Mori T; Kohno K; Kuwano M
    Anticancer Drug Des; 1989 Aug; 4(2):125-35. PubMed ID: 2803461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of P-glycoprotein associated multidrug resistance by new isoprenoid derivatives.
    Hayashi M; Koike K; Rho MC; Kuwano M; Kishiye T; Komiyama K
    Anticancer Drug Des; 2001; 16(4-5):255-60. PubMed ID: 12049484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circumvention of multiple-drug resistance in human cancer cells by thioridazine, trifluoperazine, and chlorpromazine.
    Akiyama S; Shiraishi N; Kuratomi Y; Nakagawa M; Kuwano M
    J Natl Cancer Inst; 1986 May; 76(5):839-44. PubMed ID: 3457971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of duration of exposure to S9788, cyclosporin A or verapamil on sensitivity of multidrug resistant cells to vincristine or doxorubicin.
    Pérez V; Pierré A; Léonce S; Anstett M; Atassi G
    Anticancer Res; 1993; 13(4):985-90. PubMed ID: 8352569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pervilleine F, a new tropane alkaloid aromatic ester that reverses multidrug resistance.
    Mi Q; Cui B; Lantvit D; Reyes-Lim E; Chai H; Pezzuto JM; Kinghorn AD; Swanson SM
    Anticancer Res; 2003; 23(5A):3607-15. PubMed ID: 14666656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel mechanism of N-solanesyl-N,N'-bis(3,4-dimethoxybenzyl)ethylenediamine in potentiation of antitumor drug action on multidrug-resistant and sensitive Chinese hamster cells.
    Tomida A; Tatsuta T; Suzuki H
    Jpn J Cancer Res; 1991 Jan; 82(1):127-33. PubMed ID: 1671855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced drug accumulation in multiply drug-resistant human KB carcinoma cell lines.
    Fojo A; Akiyama S; Gottesman MM; Pastan I
    Cancer Res; 1985 Jul; 45(7):3002-7. PubMed ID: 4005839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation of 1-beta-D-arabinofuranosylcytosine resistance in human KB epidermoid carcinoma cells upon induction of a second resistance to vincristine.
    Sone S; Ishii K; Tsuruo T
    Cancer Res; 1986 Jun; 46(6):3099-104. PubMed ID: 3698026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of anticancer agents by new synthetic isoprenoids. I. Inhibition of the growth of cultured mammalian cells.
    Ikezaki K; Yamaguchi T; Miyazaki C; Ueda H; Kishiye T; Tahara Y; Koyama H; Takahashi T; Fukawa H; Komiyama S
    J Natl Cancer Inst; 1984 Oct; 73(4):895-901. PubMed ID: 6592386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Most drugs that reverse multidrug resistance also inhibit photoaffinity labeling of P-glycoprotein by a vinblastine analog.
    Akiyama S; Cornwell MM; Kuwano M; Pastan I; Gottesman MM
    Mol Pharmacol; 1988 Feb; 33(2):144-7. PubMed ID: 2893251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combined effect of bleomycin and SDB-ethylenediamine, a synthetic isoprenoid, on oral squamous carcinoma cell lines and transplantable nude mouse tumors].
    Takahashi Y; Urade M; Kishimoto H; Arimoto T; Yanagisawa T; Yoshioka W
    Gan To Kagaku Ryoho; 1995 Jun; 22(7):883-7. PubMed ID: 7540824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced daunomycin accumulation in drug-sensitive and multidrug-resistant human carcinoma KB cells following phorbol ester treatment: a potential role for protein kinase C in reducing drug influx.
    Drew L; Groome N; Warr JR; Rumsby MG
    Oncol Res; 1996; 8(6):249-57. PubMed ID: 8895200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Circumvention of the intrinsic multidrug-resistance in renal cell carcinoma].
    Kakehi Y; Segawa T; Hashimura T; Yoshida O
    Hinyokika Kiyo; 1992 Nov; 38(11):1319-24. PubMed ID: 1485588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.